Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Alexion Pharmaceuticals Inc
April 19, 2026
Alexion Pharmaceuticals Inc
Investment: Designated
treatment of malignant glioma
Disease Area:
Rare Diseases
Source
Scroll to Top